Medicared For All Logo

Michael Morse MD in Durham, North Carolina

Home North Carolina Durham

Michael Morse MD has Medical Oncology as his primary medical specialty. Their primary office is: 2301 Erwin Rd in Durham, North Carolina. There are 3 additional office locations for Michael Morse MD that can be viewed towards the end of their profile.

They're a part of the: Duke Health Integrated Practice Inc medical group which has around 2,539 members. You can call their office at 919-684-8111 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended Yale University School Of Medicine and graduated in 1990 (around 34 years of experience). They are listed as doing telehealth appointments.


Michael A Morse MD Office Phone and Directions

Michael Morse MD
Duke Health Integrated Practice Inc
2301 Erwin Rd
Durham, North Carolina 27705
919-684-8111


Patient Ratings
Please rate your experience with Michael Morse MD below to help others make a more informed decision. Thanks!
Current Rating: Loading...

Phone: 919-684-8111


Enter a starting address:


Healthcare Info for Michael Morse MD

Medical School: Yale University School Of Medicine
Graduation Year: 1990
The Primary Medical Specialty for Michael Morse MD is listed as: Medical Oncology
Credentials: MD
Additional Credentials:
Approximate Years of Experience: 34
PAC (PECOS ID)#: 4385659366
NPI #: 1588748479
NPI Created On: 10/25/2006
NPI Last Updated Listed as: 05/24/2013
Primary Taxonomy Code: 207RH0003X
License Number:
96-01013
Listed Gender: Male

Insurance, Services, Charges


Forms of insurance accepted by include, but are not limited to:

  • Blue Cross Blue Shield
  • Humana
  • Ambetter
  • Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English.


Services and Procedures include:

  1. New patient office or other outpatient visit, typically 60 minutes
  2. Established patient office or other outpatient, visit typically 25 minutes
  3. Established patient office or other outpatient, visit typically 40 minutes
  4. Subsequent hospital inpatient care, typically 25 minutes per day
  5. Prolonged patient service without direct patient contact first hour
  6. Physician telephone patient service, 11-20 minutes of medical discussion
  7. Physician telephone patient service, 21-30 minutes of medical discussion

They took part in Medicare's Electronic Health Record Incentive Program which was designed to help move people over to electronic records and improve the systems that were already in place.
They took part in the Medicare Physician Quality Reporting System (PQRS).

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.


Payments Total: $1,572

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Third party is a Charity:: No

Record ID:: 792654075

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug


Payments Total: $3,240

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 819746927

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: TRUSELTIQ

Open Associated Drug #1: 72730-202-01


Payments Total: $100

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Third party is a Charity:: No

Context of payment:: Payment was made by a third party for participation in a market research study on behalf of GSK.

Record ID:: 802251969

Being Disputed:: No

Product Related: No


Payments Total: $101

Number of Payments:: 1

Form of Payment: In-kind items and services

Ownership Interest: Yes

Third party is a Charity:: No

Record ID:: 835952713

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: BioOncology

Name of Drug #1: TECENTRIQ

Open Associated Drug #1: 50242-917-01


Payments Total: $1,980

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Ownership Interest: Yes

Third party is a Charity:: No

Record ID:: 835952707

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: BioOncology

Name of Drug #1: TECENTRIQ

Open Associated Drug #1: 50242-917-01


Payments Total: $5,280

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Ownership Interest: Yes

Third party is a Charity:: No

Record ID:: 835952711

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: BioOncology

Name of Drug #1: TECENTRIQ

Open Associated Drug #1: 50242-917-01


Payments Total: $807

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Travel and Lodging City: Richmond

Travel and Lodging State: VA

Travel and Lodging Country: United States

Ownership Interest: Yes

Third party is a Charity:: No

Record ID:: 835952717

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: BioOncology

Name of Drug #1: TECENTRIQ

Open Associated Drug #1: 50242-917-01


Payments Total: $5,280

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Ownership Interest: Yes

Third party is a Charity:: No

Record ID:: 835952719

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: BioOncology

Name of Drug #1: TECENTRIQ

Open Associated Drug #1: 50242-917-01


Payments Total: $29

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Ownership Interest: Yes

Third party is a Charity:: No

Record ID:: 835952723

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: BioOncology

Name of Drug #1: TECENTRIQ

Open Associated Drug #1: 50242-917-01


Payments Total: $23

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Travel and Lodging City: Nashville

Travel and Lodging State: TN

Travel and Lodging Country: United States

Ownership Interest: Yes

Third party is a Charity:: No

Record ID:: 835952725

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: BioOncology

Name of Drug #1: TECENTRIQ

Open Associated Drug #1: 50242-917-01


Additional Office Locations

1. Duke Health Integrated Practice Inc
2351 Erwin Rd
Durham, NC 27705
Group Members: 2,539

Phone: 919-684-8111

Enter a starting address:


2. Duke Health Integrated Practice Inc
20 Duke Medicine Cir
Durham, NC 27710
Group Members: 2,539

Phone: 919-684-8111

Enter a starting address:


3. Duke Health Integrated Practice Inc
40 Duke Medicine Cir
Durham, NC 27710
Group Members: 2,539

Phone: 919-684-8111

Enter a starting address:


Medical Oncology Professionals in Durham

20 Duke Medicine Cir
Durham, NC
Duke Health Integrated Practice Inc

40 Duke Medicine Cir
Durham, NC
Duke Health Integrated Practice Inc

40 Duke Medicine Cir
Durham, NC
Duke Health Integrated Practice Inc

2301 Erwin Rd
Durham, NC
Duke Health Integrated Practice Inc

2351 Erwin Rd
Durham, NC
Duke Health Integrated Practice Inc

40 Duke Medicine Cir
Durham, NC
Duke Health Integrated Practice Inc

Providers in Duke Health Integrated Practice Inc

1.James Abbruzzese

20 Duke Medicine Cir
Durham Nc 27710-2000
Duke Health Integrated Practice Inc
Medical Oncology

2.James Abbruzzese

40 Duke Medicine Cir
Durham Nc 27710-4000
Duke Health Integrated Practice Inc
Medical Oncology

3.Nandini Abburi

2301 Erwin Rd
Durham Nc 27705-4699
Duke Health Integrated Practice Inc
Neurology

4.Nandini Abburi

2351 Erwin Rd
Durham Nc 27705-4699
Duke Health Integrated Practice Inc
Neurology

5.Nandini Abburi

40 Duke Medicine Cir
Durham Nc 27710-4000
Duke Health Integrated Practice Inc
Neurology

6.Muhammad Abd-el-barr

5601 Arringdon Park Dr
Morrisville Nc 27560-5676
Duke Health Integrated Practice Inc
Neurosurgery

View all 2,539 members of Duke Health Integrated Practice Inc medical group